The complex world of sleep apnea care just got a significant boost, as Ognomy Sleep announced it has secured $20.0M in Series A funding. The capital infusion, led by Catalyst Investors and joined by Blue Heron Capital, Impellent Ventures, Launch NY, Excell Partners, and University at Buffalo, will fuel the company's mission to streamline diagnosis and treatment. Ognomy's proprietary technology and virtual network connect patients, specialists, and smart wearables, facilitating home-sleep testing and comprehensive care options worldwide.


















